FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.5  |  FHIR Version n/a  User: [n/a]

773879000: Antineoplastic therapeutic role (role)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2019. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3726859011 Antineoplastic therapeutic role en Synonym Active Entire term case insensitive SNOMED CT core module
3726860018 Antineoplastic therapeutic role (role) en Fully specified name Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Antineoplastic therapeutic role Is a Therapeutic role true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Fluorouracil 3950mg/105ml in Sodium chloride 0.9% infusion elastomeric devices Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Asparaginase 10,000unit powder for solution for injection vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Methotrexate 7.5mg/0.75ml solution for injection pre-filled syringes Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Fluorouracil 250mg/10ml solution for injection vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Ipilimumab 200mg/40ml solution for infusion vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Bosutinib 500mg tablets Plays role False Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Carboplatin 270mg/500ml in Glucose 5% infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Olaparib 150mg tablets Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Fluorouracil 3150mg/105ml in Sodium chloride 0.9% infusion elastomeric devices Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Tioguanine 50mg/5ml oral suspension Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Fluorouracil 7250mg/300ml in Sodium chloride 0.9% infusion elastomeric devices Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Irinotecan 400mg/250ml in Sodium chloride 0.9% infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Anastrozole 1mg/5ml oral solution Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Docetaxel 80mg/2ml solution for injection vials and diluent Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Temozolomide 50mg/5ml oral suspension Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Hydroxycarbamide 500mg/5ml oral suspension Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Mitomycin 0.02% eye drops Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Methotrexate 20mg/0.4ml solution for injection pre-filled syringes Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Panobinostat 10mg capsules Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Cisplatin 89mg/500ml in Sodium chloride 0.9% infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Methotrexate 50mg/2ml solution for injection pre-filled syringes Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Interferon beta-1a 12million units/0.5ml solution for injection 1.5ml cartridges Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Mercaptopurine 30mg capsules Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Busulfan 2mg/5ml oral solution Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Cyclophosphamide 40mg/5ml oral suspension Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Mercaptopurine 45mg/5ml oral suspension Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Doxorubicin 100mg/50ml solution for infusion vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Bevacizumab 1.25mg/0.05ml solution for injection pre-filled syringes Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Carboplatin 300mg/500ml in Glucose 5% infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Nivolumab 240mg/24ml solution for infusion vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Carboplatin 600mg/60ml solution for injection vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Docetaxel 200mg/500ml in Sodium chloride 0.9% infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Mercaptopurine 12.5mg capsules Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Obinutuzumab 1g/40ml solution for infusion vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Cisplatin 40mg/250ml in Sodium chloride 0.9% infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Carboplatin 50mg/5ml solution for injection vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Cisplatin 70mg/500ml in Sodium chloride 0.9% infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Panobinostat 20mg capsules Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Gemcitabine 2g/200ml infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Irinotecan 220mg/250ml in Sodium chloride 0.9% infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Methotrexate 18mg/5ml oral solution Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Cyclophosphamide 600mg/30ml solution for injection pre-filled syringes Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Imatinib 100mg capsules Plays role False Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Fluorouracil 5650mg/130ml in Sodium chloride 0.9% infusion elastomeric devices Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Nintedanib 150mg capsules Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Methotrexate 12.5mg/0.25ml solution for injection pre-filled disposable devices Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Epirubicin 20mg/10ml solution for injection pre-filled syringes Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Docetaxel 140mg/7ml solution for infusion vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Fluorouracil 2.5g/50ml solution for infusion vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Irinotecan 300mg/15ml solution for infusion vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Mitomycin 20mg powder and solvent for intravesical solution vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Panitumumab 400mg/20ml solution for injection vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Bevacizumab 400mg/16ml solution for infusion vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Peginterferon alfa-2b (rbe) 120microgram powder and solvent for solution for injection pre-filled disposable devices Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Methotrexate 20mg/0.8ml solution for injection pre-filled syringes Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Doxorubicin 60mg/30ml solution for injection pre-filled syringes Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Interferon beta-1a 6million units/0.5ml solution for injection pre-filled devices and Interferon beta-1a 2.4million units/0.2ml solution for injection pre-filled devices Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Fluorouracil 2800mg/300ml in Sodium chloride 0.9% infusion elastomeric devices Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Trametinib 2mg tablets Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Cisplatin 10mg/10ml solution for injection vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Methotrexate 1mg/5ml oral suspension Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Cyclophosphamide 50mg/5ml oral suspension Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Methotrexate 12.5mg/0.25ml solution for injection pre-filled syringes Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Pemetrexed 100mg powder for solution for injection vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Decitabine 50mg powder for solution for infusion vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Methotrexate 10mg/1ml solution for injection pre-filled syringes Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Hydroxycarbamide 500mg/5ml oral solution Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Cetuximab 100mg/50ml solution for injection vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Irinotecan 360mg/240ml infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Everolimus 5mg dispersible tablets sugar free Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Peginterferon alfa-2a 135micrograms/0.5ml solution for injection pre-filled disposable devices Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Methotrexate 50mg/5ml oral suspension Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Bevacizumab 100mg/4ml solution for infusion vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Fluorouracil 950mg/38ml solution for injection pre-filled syringes Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Mercaptopurine 75mg tablets Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Interferon alfa-2b (rbe) 3million unit powder and solvent for solution for injection vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Fluorouracil 6400mg/200ml in Sodium chloride 0.9% infusion elastomeric devices Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Fluorouracil 3950mg/120ml in Sodium chloride 0.9% infusion elastomeric devices Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Cisplatin 50mg powder for solution for injection vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Hydroxycarbamide 1g tablets Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Cyclophosphamide 40mg/5ml oral solution Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Irinotecan 300mg/200ml infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Dasatinib 140mg tablets Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Methotrexate 2.5mg/5ml oral suspension Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Vincristine 2mg/50ml infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Oxaliplatin 50mg/10ml solution for injection vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Enzalutamide 40mg tablets Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Methotrexate 17.5mg/0.35ml solution for injection pre-filled disposable devices Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Methotrexate 12.5mg/5ml oral solution Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Methotrexate 7.5mg/0.3ml solution for injection pre-filled disposable devices Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Methotrexate 25mg/2.5ml solution for injection pre-filled syringes Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Vinblastine 10mg/10ml solution for injection vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Letrozole 2.5mg/5ml oral suspension Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Cisplatin 185mg/1000ml in Sodium chloride 0.9% infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Lenalidomide 20mg capsules Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Peginterferon alfa-2b 80microgram powder and solvent for solution for injection vials Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Fluorouracil 3500mg/130ml in Sodium chloride 0.9% infusion elastomeric devices Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Methotrexate 30mg/0.6ml solution for injection pre-filled disposable devices Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Fluorouracil 5650mg/200ml in Sodium chloride 0.9% infusion elastomeric devices Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Lenalidomide 7.5mg capsules Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier
Docetaxel 148mg/250ml in Sodium chloride 0.9% infusion bags Plays role True Antineoplastic therapeutic role Inferred relationship Existential restriction modifier

Start Previous Page 19 of 26 Next End

This concept is not in any reference sets

Back to Start